Clinical Evaluation for Sarcoma Originated From Bone (CESOFB)
Sponsor: Peking University People's Hospital
This observational or N/A phase trial investigates Histological Response and Sensitivity and is currently ongoing. Peking University People's Hospital leads this study, which shows 8 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status
-
Dec 2020 — Jan 2021 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Dec 2018 — Dec 2020 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
▶ Show 3 earlier versions
-
Jun 2018 — Dec 2018 [monthly]
Not Yet Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Not Yet Recruiting
Phase: NA → None
-
Dec 2017 — Apr 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Peking University People's Hospital
- Second Affiliated Hospital, School of Medicine, Zhejiang University
- Xijing Hospital
For direct contact, visit the study record on ClinicalTrials.gov .